Methodology
Our GLP-1 buyer’s guides use the scoring weights below to compare sellers. This page explains how we assess price, what evidence we record, and where commercial relationships affect the order in which sellers appear.
How a score is calculated
Each provider score combines 5 criteria using the weights below. The score and the order in which providers appear on a board are separate. The editorial policy explains how we document the sources behind those criteria.
Price transparency
20%Can you find what a month costs — for the molecule and the form you want — before creating an account, and does the seller's own site agree with itself?
Honest headline
35%Is the figure the seller leads with the figure it bills? A price that needs a twelve-month prepay, or that is struck through from an anchor nobody pays, is a different number from a standing monthly rate.
Dose-ladder pricing
35%Does the price hold as your dose escalates, or is it re-set at every step? This is the difference most buyers only discover in month three.
State coverage
5%How much of the country the seller ships to. It decides whether a price is available to you at all, but nearly every seller here covers most of it, so it separates almost nobody.
Molecule and form breadth
5%Whether the seller carries both molecules and both delivery forms. Useful context beside a price; not what this site ranks on.
The scoring function does not read commercial status. Category pages can show partners first with a “Partner” label. The same scoring criteria apply to each provider.
30 of the 579 sellers we rank pay us a commission. The seller our rubric places first, bmiMD, is one of them — which is the case we hold ourselves to hardest, so here is the working: every mark is derived from published facts, none of them commercial, and you can recompute any score from the seller’s own page. Partner status changes where a row sits on a board, and never the number beside it.
- 01
Primary sources, never summaries
We use trial publications and official labels for clinical evidence. For provider terms and costs, we consult the source that sets the terms.
- 02
How citations are checked
Citation checks verify the identity and status of referenced studies. A factual review checks the claim against the underlying source.
- 03
Magnitude over vibes
We report effect sizes, hazard ratios, confidence intervals, and durations — not adjectives. Where evidence is preclinical or thin, we say so plainly rather than implying more than the data supports.
- 04
Independence, disclosed
Buy This GLP earns revenue through clearly labeled partnerships with vetted telehealth and pharmacy providers. Paid placement can affect display order. The provider score uses the criteria listed above.
- 05
Research, not medical advice
Our work is educational. It is not a substitute for an individualized consultation with a licensed clinician, and the medical disclaimer explains the limits of that information.